Jump Financial LLC Raises Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jump Financial LLC raised its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 61.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 55,573 shares of the medical instruments supplier’s stock after buying an additional 21,244 shares during the quarter. Jump Financial LLC’s holdings in DENTSPLY SIRONA were worth $1,055,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Bridgewater Associates LP grew its position in DENTSPLY SIRONA by 24.4% during the fourth quarter. Bridgewater Associates LP now owns 225,523 shares of the medical instruments supplier’s stock worth $4,280,000 after buying an additional 44,171 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $693,000. Mariner LLC grew its holdings in shares of DENTSPLY SIRONA by 103.7% during the fourth quarter. Mariner LLC now owns 491,550 shares of the medical instruments supplier’s stock worth $9,330,000 after purchasing an additional 250,219 shares in the last quarter. Barclays PLC increased its position in shares of DENTSPLY SIRONA by 13.8% in the fourth quarter. Barclays PLC now owns 349,112 shares of the medical instruments supplier’s stock worth $6,625,000 after purchasing an additional 42,303 shares during the last quarter. Finally, Sterling Capital Management LLC raised its stake in DENTSPLY SIRONA by 53.9% in the fourth quarter. Sterling Capital Management LLC now owns 12,144 shares of the medical instruments supplier’s stock valued at $230,000 after purchasing an additional 4,254 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $12.83 on Monday. The stock has a market capitalization of $2.56 billion, a price-to-earnings ratio of -6.20, a PEG ratio of 1.80 and a beta of 0.92. The firm’s 50-day moving average price is $15.61 and its two-hundred day moving average price is $18.64. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $31.00.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.99%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.52% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of research analyst reports. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Evercore ISI restated an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Mizuho cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Thirteen analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $22.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.